CD14 and uveitis: We found that increased NCM characterized by CD14-CD16+, HLA DR on CD14-CD16+ and PDL-1 on CD14-CD16+ were associated with a decreased risk of uveitis, suggesting that an increase in NCM may be associated with enhanced vascular anti-inflammatory effects.